Carlos Leprevost, MD, MBA, PhD
Medical Manager - Rare diseases at Saventic Health- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Inglês Native or bilingual proficiency
-
Espanhol Full professional proficiency
-
Portuguese Native or bilingual proficiency
-
French Elementary proficiency
Topline Score
Bio
Rachel Mador-House, CGC, MSc, MSc
Wow, where to start? Carlos is undeniably brilliant but is also a kind person and wonderful team member. He took the time to share his knowledge freely and always made time to meet with me and answer my questions. He is an exceptional team member and brilliant physician scientist. I feel very lucky to have worked with him and am a better clinician and scientist myself because of him.
Caio Graco Bruzaca
Doctor Carlos Leprevost is a great clinical geneticist. My first choice if I need to referee to treatment and care of rare diseases. He’s emphaty with minorities and people with disabilities, such as people with rare diseases makes him a high level professional and a marvelous doctor that helped hundreds of patients who need a genetic diagnosis. I appreciate the opportunity to have him as a colleague, and I’ve learned a lot about treatment of rare disease with him. Thank You Carlos!
Rachel Mador-House, CGC, MSc, MSc
Wow, where to start? Carlos is undeniably brilliant but is also a kind person and wonderful team member. He took the time to share his knowledge freely and always made time to meet with me and answer my questions. He is an exceptional team member and brilliant physician scientist. I feel very lucky to have worked with him and am a better clinician and scientist myself because of him.
Caio Graco Bruzaca
Doctor Carlos Leprevost is a great clinical geneticist. My first choice if I need to referee to treatment and care of rare diseases. He’s emphaty with minorities and people with disabilities, such as people with rare diseases makes him a high level professional and a marvelous doctor that helped hundreds of patients who need a genetic diagnosis. I appreciate the opportunity to have him as a colleague, and I’ve learned a lot about treatment of rare disease with him. Thank You Carlos!
Rachel Mador-House, CGC, MSc, MSc
Wow, where to start? Carlos is undeniably brilliant but is also a kind person and wonderful team member. He took the time to share his knowledge freely and always made time to meet with me and answer my questions. He is an exceptional team member and brilliant physician scientist. I feel very lucky to have worked with him and am a better clinician and scientist myself because of him.
Caio Graco Bruzaca
Doctor Carlos Leprevost is a great clinical geneticist. My first choice if I need to referee to treatment and care of rare diseases. He’s emphaty with minorities and people with disabilities, such as people with rare diseases makes him a high level professional and a marvelous doctor that helped hundreds of patients who need a genetic diagnosis. I appreciate the opportunity to have him as a colleague, and I’ve learned a lot about treatment of rare disease with him. Thank You Carlos!
Rachel Mador-House, CGC, MSc, MSc
Wow, where to start? Carlos is undeniably brilliant but is also a kind person and wonderful team member. He took the time to share his knowledge freely and always made time to meet with me and answer my questions. He is an exceptional team member and brilliant physician scientist. I feel very lucky to have worked with him and am a better clinician and scientist myself because of him.
Caio Graco Bruzaca
Doctor Carlos Leprevost is a great clinical geneticist. My first choice if I need to referee to treatment and care of rare diseases. He’s emphaty with minorities and people with disabilities, such as people with rare diseases makes him a high level professional and a marvelous doctor that helped hundreds of patients who need a genetic diagnosis. I appreciate the opportunity to have him as a colleague, and I’ve learned a lot about treatment of rare disease with him. Thank You Carlos!
Credentials
-
Clinical Case Challenge: Can You Effectively Manage Patients With NF1-Associated Tumors?
MedscapeDec, 2022- Sep, 2024 -
Ending the Diagnostic Odyssey: Genetic Diagnosis in Children Affected by Epilepsy
MedscapeDec, 2022- Sep, 2024 -
Primary Hyperoxaluria: Assessing Practice Patterns in Diagnosis and Management
MedscapeDec, 2022- Sep, 2024 -
Hemophilia Gene Therapy: Readying for Clinical Care
The France FoundationOct, 2022- Sep, 2024 -
2022 Brazilian Congress of Medical Genetics
Sociedade Brasileira de Genética Médica e Genômica - SBGMSep, 2022- Sep, 2024 -
Comunicação Comercial Responsável
PfizerAug, 2022- Sep, 2024 -
Interfarma | Treinamento do Novo Código de Conduta 2022
InterfarmaAug, 2022- Sep, 2024 -
MAPP: Anti-Bribery and Anti-Corruption Training
PfizerAug, 2022- Sep, 2024 -
Principios Globais de Privacidade para a Indústria Farmacêutica
PfizerAug, 2022- Sep, 2024 -
Ace the Case: A 22-Year-Old Man With Hemophilia A and Knee Pain/Swelling
Vindico Medical EducationJul, 2022- Sep, 2024 -
Gene Therapy Advances in Clinical Trials
International Society on Thrombosis and Haemostasis (ISTH)Jul, 2022- Sep, 2024 -
Gene Therapy in Hemophilia: ASPTH 2021 Enduring
The France FoundationJul, 2022- Sep, 2024 -
Gene Therapy on DMD and LGMD
The France FoundationJul, 2022- Sep, 2024 -
How to Train Your Brain For Happiness
LinkedInJul, 2022- Sep, 2024 -
Obesity Management in Practice: Strategies for Multiple Specialty Clinics
MedscapeJul, 2022- Sep, 2024 -
The Future of Duchenne Muscular Dystrophy: Understanding the Science Behind Emerging Gene Therapies
MedscapeJul, 2022- Sep, 2024 -
The New Cardiometabolic Strategy From A to Z: Cardiometabolic Strategy to Treat T2D
MedscapeJul, 2022- Sep, 2024 -
Atomic Habits (Blinkist Summary)
LinkedInJun, 2022- Sep, 2024 -
Being Positive at Work
LinkedInJun, 2022- Sep, 2024 -
Building Resilience
LinkedInJun, 2022- Sep, 2024 -
Conformidade com a LGPD: O Impacto em Empresas Brasileiras
LinkedInJun, 2022- Sep, 2024 -
Counterintuitive Leadership Strategies for a VUCA (Volatile, Uncertain, Complex, Ambiguous) Environment
LinkedInJun, 2022- Sep, 2024 -
Developing Executive Presence
LinkedInJun, 2022- Sep, 2024 -
Emotional Intelligence as an Inclusivity Booster
LinkedInJun, 2022- Sep, 2024 -
Humble Leadership: The Power of Relationships, Openness, and Trust (getAbstract Summary)
LinkedInJun, 2022- Sep, 2024 -
Leadership Presence in Action
LinkedInJun, 2022- Sep, 2024 -
Out and Proud: Approaching LGBT Issues in the Workplace
LinkedInJun, 2022- Sep, 2024 -
Performing under Pressure
LinkedInJun, 2022- Sep, 2024 -
Strategic Thinking
LinkedInJun, 2022- Sep, 2024 -
The Six Morning Habits of High Performers
LinkedInJun, 2022- Sep, 2024 -
Best Practices for New People Leaders
LinkedInMar, 2022- Sep, 2024 -
Capacitação em Genética das Arritmias Cardíacas (speaker)
SOBRAC - Sociedade Brasileira de Arritmias CardíacasOct, 2021- Sep, 2024 -
Simposio de Cardiomiopatias e Arritmias Genéticamente Condicionadas (speaker)
Sociedade Brasileira de CardiologiaAug, 2021- Sep, 2024 -
Educagene - educação médica continuada em genética (speaker)
Brazilian Society of Medical Genetics and GenomicsDec, 2020- Sep, 2024 -
Certification of Special Qualifications for Endocrinology
IPEMED Afya EducacionalApr, 2018- Sep, 2024 -
Certification in Medical Genetics (MG)
Brazilian Society of Medical Genetics and GenomicsJun, 2016- Sep, 2024 -
Certification of Special Qualification for Neurogenetics
Duke UniversityApr, 2016- Sep, 2024 -
Genes and the Human Condition (From Behavior to Biotechnology)
CourseraAug, 2014- Sep, 2024
Experience
-
Saventic Health
-
Poland
-
Technology, Information and Internet
-
1 - 100 Employee
-
Medical Manager - Rare diseases
-
Jul 2023 - Present
Rare Diseases Medical Manager - Brazilian BU - (i) supporting from a medical standpoint in developing algorithms and provide the expertise medical know-how based on the Company request, - (ii) giving the legal possibility in presenting the Service provider on Company’s websites i.e. www.saventic.com as well as the platform for patients www.saventiccare.com.br, - (iii) supporting as an expert in the evaluation of the Company's algorithms and reviewing patients’ data for the Brazilian market to adapt the NLP output to the local IT systems and specific medical vocabulary, - (iv) cooperation with the Company’s Virtual Clinic Platform as an expert, support in referring patients with a suspected rare disease to the appropriate specialist center or evaluating medical content available on the Virtual Clinics’ or Saventic’s website, Show less
-
-
-
Further Group
-
Spain
-
Insurance
-
1 - 100 Employee
-
Medical Science Liaison - Oncology
-
Mar 2023 - Present
Member of molecular tumour board. Germline and Somatics oncology NGS expert. Member of molecular tumour board. Germline and Somatics oncology NGS expert.
-
-
-
Prefeitura Municipal de Tijucas do Sul
-
Brazil
-
Government Administration
-
1 - 100 Employee
-
Médico coordenador - Ambulatório de Neurologia Infantil e Neurodesenvolvimento
-
Nov 2022 - Present
Coordenador Ambulatório neurologia infantil / Neurodesenvolvimento / epilepsias / Neurodivergência / deficiência intelectual / transtorno do espectro autista / doenças raras Planejamento de políticas públicas em conjunto com secretarias municipais Time multidisciplinar de atenção secundária a saúde em neuropediatria e doenças raras Coordenador Ambulatório neurologia infantil / Neurodesenvolvimento / epilepsias / Neurodivergência / deficiência intelectual / transtorno do espectro autista / doenças raras Planejamento de políticas públicas em conjunto com secretarias municipais Time multidisciplinar de atenção secundária a saúde em neuropediatria e doenças raras
-
-
-
Instituto de Genética Médica - Dr. Carlos Leprevost
-
Brazil
-
Medical Practices
-
Geneticist, MD - patient care
-
Jul 2012 - Present
CEO Rare diseases physician CEO Rare diseases physician
-
-
-
Invitae
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Medical Director - Genetic Testing - LATAM
-
Mar 2021 - Feb 2023
Science ambassador of Invitae with clinicians, academic institutions, and professional organizations, responsible for provide support to clinicians who do not have access to genetic counselors or genetics expertise; help them implement a screening program for risk assessment, pre-test counseling and delivering results Provide scientific and clinical presentations on Invitae’s product, with focus on genetic testing Build relationships with thought leaders and key decision makers Support and educate internal customers (sales, marketing, lab, client services) as it relates to clinical expertise Support health care providers by offering clinical information/education that helps guide medical decisions Develop educational materials for healthcare providers and patients Collect and report market information within company guidelines Attend regional and national tradeshows and medical conferences Collaborate with medical societies and organizations and advocacy groups Demonstrate expert knowledge in related clinical and disease states Show less
-
-
-
Google
-
United States
-
Software Development
-
700 & Above Employee
-
Medical Manager - Regulatory Affairs
-
Jul 2017 - Oct 2021
Compliance social media reviewer / medical informations (YouTube/Google) Compliance social media reviewer / medical informations (YouTube/Google)
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Medical Manager - Oncology
-
Jun 2020 - May 2021
Medical management in oncogenetics and neurofibromatosis type 1. Responsible for creating the area of rare diseases at Astrazeneca and molding the medical plan and the business unit. Worked together with the market access team on ways to include the Selumetinib in the brazilian public health system after launch, emphasizing the differences between this type of market and the private one. Created a patient-centered strategy, developing patient support programs that go beyond medication, building the patient's journey. Developed a robust digital strategy, with the creation of a website for information for the general public, and continuing medical education programs for physicians. Responsible for medical field work in identifying doctors, institutions, patient associations, government and other important stakeholders for the strategy. Started cross-functional working with global and LATAM to exchange experiences and support in the global launch of Selumetinib. Show less
-
-
-
Novo Nordisk
-
Denmark
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Medical Manager - Hematology | Rare Diseases
-
Jun 2019 - Jul 2020
Medical manager - acquired haemophila, haemophilia B and rare blood disorders. Medical manager - acquired haemophila, haemophilia B and rare blood disorders.
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Medical Manager - Rare diseases
-
Nov 2018 - Jun 2019
Medical manager for Pompe's disease. Led medical plan for incorporation of Myozyme in the public health system; and in the company planning of the acquision new technologies in synergy with the franchise. Created a internal training for other areas in basic principles of genetics.Sanofi global award 2019 “Bright Idea” for best use of technology and digital innovation - app for family tree
-
-
Medical Science Liaison - Rare diseases
-
Jan 2017 - Dec 2018
Medical Science Liaison for Fabry Disease, focusing on medical education on genetic counseling. Idealized categorization of HCP according to the unmeet needs for rare diseases. Led medical plan for incorporating Fabrazyme in the public health system.2019 Sanofi global award "Field Based Medical" as the best field medical project.
-
-
Education
-
2023 - 2026
USP - Universidade de São Paulo
Doctor of Philosophy - PhD, Medical Genetics -
2016 - 2018
Universidade de São Paulo
Fellowship program, Endocrinology -
2012 - 2016
Universidade de São Paulo
Master of Science - MS, Medical Genetics Residency -
2021 - 2022
Fundação Getulio Vargas
Master of Business Administration - MBA, Management with Emphasis on Leadership and Innovation -
2015 - 2015
Health Sciences Federal University of Porto Alegre
Fellowship program, Neurogenetics -
2014 - 2014
Duke University
Fellowship program, Inborn errors of metabolism -
2011 - 2011
Universidade Federal do Paraná
Bachelor of Science - BS, Molecular Genetics -
2007 - 2012
Pontifícia Universidade Católica do Paraná
Doctor of Medicine - MD, Medicine
Community
